The table below provides the definition for this International Classification of Childhood Cancer, Third edition (ICCC-3) variable. To see other variable definitions, see the ICCC home page.
Caution: The ICCC recode in the SEER databases through the November 2011 submission incorrectly classifies some benign and borderline tumors into specific groups. Benign and borderline tumors should only be in III (all sub categories) and X(a). Please group all other benign and borderline tumors with non-classifiable. This problem was fixed starting with the November 2012 submission.
Site Group | ICD-O-3 Histology (Type) | ICD-O-2/3 Site | Recode |
---|---|---|---|
I. Leukemias, myeloproliferative diseases, and myelodysplastic diseases | |||
(a) Lymphoid leukemias | 9820, 9823, 9826, 9827, 9831-9837, 9940, 9948 | C000-C809 | 011 |
(b) Acute myeloid leukemias | 9840, 9861, 9866, 9867, 9870-9874, 9891, 9895-9897, 9910, 9920, 9931 | C000-C809 | 012 |
(c) Chronic myeloproliferative diseases | 9863, 9875, 9876, 9950, 9960-9964 | C000-C809 | 013 |
(d) Myelodysplastic syndrome and other myeloproliferative diseases | 9945, 9946, 9975, 9980, 9982-9987, 9989 | C000-C809 | 014 |
(e) Unspecified and other specified leukemias | 9800, 9801, 9805, 9860, 9930 | C000-C809 | 015 |
II. Lymphomas and reticuloendothelial neoplasms | |||
(a) Hodgkin lymphomas | 9650-9655, 9659, 9661-9665, 9667 | C000-C809 | 021 |
(b) Non-Hodgkin lymphomas (except Burkitt lymphoma) | 9591, 9670, 9671, 9673, 9675, 9678-9680, 9684, 9689-9691, 9695, 9698-9702, 9705, 9708, 9709, 9714, 9716-9719, 9727-9729, 9731-9734, 9760-9762, 9764-9769, 9970 | C000-C809 | 022 |
(c) Burkitt lymphoma | 9687 | C000-C809 | 023 |
(d) Miscellaneous lymphoreticular neoplasms | 9740-9742, 9750, 9754-9758 | C000-C809 | 024 |
(e) Unspecified lymphomas | 9590, 9596 | C000-C809 | 025 |
III. CNS and miscellaneous intracranial and intraspinal neoplasms | |||
(a) Ependymomas and choroid plexus tumor | 9383, 9390-9394 | C000-C809 | 031 |
(b) Astrocytomas | 9380 | C723 | 032 |
9384, 9400-9411, 9420, 9421-9424, 9440-9442 | C000-C809 | 032 | |
(c) Intracranial and intraspinal embryonal tumors | 9470-9474, 9480, 9508 | C000-C809 | 033 |
9501-9504 | C700-C729 | 033 | |
(d) Other gliomas | 9380 | C700-C722, C724-C729, C751, C753 | 034 |
9381, 9382, 9430, 9444, 9450, 9451, 9460 | C000-C809 | 034 | |
(e) Other specified intracranial and intraspinal neoplasms | 8270-8281, 8300, 9350-9352, 9360-9362, 9412, 9413, 9492, 9493, 9505-9507, 9530-9539, 9582 | C000-C809 | 035 |
(f) Unspecified intracranial and intraspinal neoplasms | 8000-8005 | C700-C729, C751-C753 | 036 |
IV. Neuroblastoma and other peripheral nervous cell tumors | |||
(a) Neuroblastoma and ganglioneuroblastoma | 9490, 9500 | C000-C809 | 041 |
(b) Other peripheral nervous cell tumors | 8680-8683, 8690-8693, 8700, 9520-9523 | C000-C809 | 042 |
9501-9504 | C000-C699, C739-C768, C809 | 042 | |
V. Retinoblastoma | 9510-9514 | C000-C809 | 050 |
VI. Renal tumors | |||
(a) Nephroblastoma and other nonepithelial renal tumors | 8959, 8960, 8964-8967 | C000-C809 | 061 |
8963, 9364 | C649 | 061 | |
(b) Renal carcinomas | 8010-8041, 8050-8075, 8082, 8120-8122, 8130-8141, 8143, 8155, 8190-8201, 8210, 8211, 8221-8231, 8240, 8241, 8244-8246, 8260-8263, 8290, 8310, 8320, 8323, 8401, 8430, 8440, 8480-8490, 8504, 8510, 8550, 8560-8576 | C649 | 062 |
8311, 8312, 8316-8319, 8361 | C000-C809 | 062 | |
(c) Unspecified malignant renal tumors | 8000-8005 | C649 | 063 |
VII. Hepatic tumors | |||
(a) Hepatoblastoma | 8970 | C000-C809 | 071 |
(b) Hepatic carcinomas | 8010-8041, 8050-8075, 8082, 8120-8122, 8140, 8141, 8143, 8155, 8190-8201, 8210, 8211, 8230, 8231, 8240, 8241, 8244-8246, 8260-8264, 8310, 8320, 8323, 8401, 8430, 8440, 8480-8490, 8504, 8510, 8550, 8560-8576 | C220, C221 | 072 |
8160-8180 | C000-C809 | 072 | |
(c) Unspecified malignant hepatic tumors | 8000-8005 | C220, C221 | 073 |
VIII. Malignant bone tumors | |||
(a) Osteosarcomas | 9180-9187, 9191-9195, 9200 | C400-C419, C760-C768, C809 | 081 |
(b) Chondrosarcomas | 9210, 9220, 9240 | C400-C419, C760-C768, C809 | 082 |
9221, 9230, 9241-9243 | C000-C809 | 082 | |
(c) Ewing tumor and related sarcomas of bone | 9260 | C400-C419, C760-C768, C809 | 083 |
9363-9365 | C400-C419 | 083 | |
(d) Other specified malignant bone tumors | 8810, 8811, 8823, 8830 | C400-C419 | 084 |
8812, 9250, 9261, 9262, 9270-9275, 9280-9282, 9290, 9300-9302, 9310-9312, 9320-9322, 9330, 9340-9342, 9370-9372 | C000-C809 | 084 | |
(e) Unspecified malignant bone tumors | 8000-8005, 8800, 8801, 8803-8805 | C400-C419 | 085 |
IX. Soft tissue and other extraosseous sarcomas | |||
(a)Rhabdomyosarcomas | 8900-8905, 8910, 8912, 8920, 8991 | C000-C809 | 091 |
(b) Fibrosarcomas, peripheral nerve sheath tumors, and other fibrous neoplasms | 8810, 8811, 8813-8815, 8821, 8823, 8834-8835 | C000-C399, C440-C768, C809 | 092 |
8820, 8822, 8824-8827, 9150, 9160, 9491, 9540-9571, 9580 | C000-C809 | 092 | |
(c) Kaposi sarcoma | 9140 | C000-C809 | 093 |
(d) Other specified soft tissue sarcomas | 8587, 8710-8713, 8806, 8831-8833, 8836, 8840-8842, 8850-8858, 8860-8862, 8870, 8880, 8881, 8890-8898, 8921, 8982, 8990, 9040-9044, 9120-9125, 9130-9133, 9135, 9136, 9141, 9142, 9161, 9170-9175, 9231, 9251, 9252, 9373, 9581 | C000-C809 | 094 |
8830 | C000-C399, C440-C768, C809 | 094 | |
8963 | C000-C639, C659-C699, C739-C768, C809 | 094 | |
9180, 9210, 9220, 9240 | C490-C499 | 094 | |
9260 | C000-C399, C470-C759 | 094 | |
9364 | C000-C399, C470-C639, C659-C699, C739-C768, C809 | 094 | |
9365 | C000-C399, C470-C639, C659-C768, C809 | 094 | |
(e) Unspecified soft tissue sarcomas | 8800-8805 | C000-C399, C440-C768, C809 | 095 |
X. Germ cell tumors, trophoblastic tumors, and neoplasms of gonads | |||
(a) Intracranial and intraspinal germ cell tumors | 9060-9065, 9070-9072, 9080-9085, 9100, 9101 | C700-C729, C751-C753 | 101 |
(b) Malignant extracranial and extragonadal germ cell tumors | 9060-9065, 9070-9072, 9080-9085, 9100-9105 | C000-C559, C570-C619, C630-C699, C739-C750, C754-C768, C809 | 102 |
(c) Malignant gonadal germ cell tumors | 9060-9065, 9070-9073, 9080-9085, 9090, 9091, 9100, 9101 | C569, C620-C629 | 103 |
(d) Gonadal carcinomas | 8010-8041, 8050-8075, 8082, 8120-8122, 8130-8141, 8143, 8190-8201, 8210, 8211, 8221-8241, 8244-8246, 8260-8263, 8290, 8310, 8313, 8320, 8323, 8380-8384, 8430, 8440, 8480-8490, 8504, 8510, 8550, 8560-8573, 9000, 9014, 9015 | C569, C620-C629 | 104 |
8441-8444, 8450, 8451, 8460-8473 | C000-C809 | 104 | |
(e) Other and unspecified malignant gonadal tumors | 8590-8671 | C000-C809 | 105 |
8000-8005 | C569, C620-C629 | 105 | |
XI. Other malignant epithelial neoplasms and malignant melanomas | |||
(a) Adrenocortical carcinomas | 8370-8375 | C000-C809 | 111 |
(b) thyroid carcinomas | 8010-8041, 8050-8075, 8082, 8120-8122, 8130-8141, 8190, 8200, 8201, 8211, 8230, 8231, 8244-8246, 8260-8263, 8290, 8310, 8320, 8323, 8430, 8440, 8480, 8481, 8510, 8560-8573 | C739 | 112 |
8330-8337, 8340-8347, 8350 | C000-C809 | 112 | |
(c) Nasopharyngeal carcinomas | 8010-8041, 8050-8075, 8082, 8083, 8120-8122, 8130-8141, 8190, 8200, 8201, 8211, 8230, 8231, 8244-8246, 8260-8263, 8290, 8310, 8320, 8323, 8430, 8440, 8480, 8481, 8500-8576 | C110-C119 | 113 |
(d) Malignant melanomas | 8720-8780, 8790 | C000-C809 | 114 |
(e) Skin carcinomas | 8010-8041, 8050-8075, 8078, 8082, 8090-8110, 8140, 8143, 8147, 8190, 8200, 8240, 8246, 8247, 8260, 8310, 8320, 8323, 8390-8420, 8430, 8480, 8542, 8560, 8570-8573, 8940, 8941 | C440-C449 | 115 |
(f) Other and unspecified carcinomas | 8010-8084, 8120-8157, 8190-8264, 8290, 8310, 8313-8315, 8320-8325, 8360, 8380-8384, 8430-8440, 8452-8454, 8480-8586, 8588-8589, 8940, 8941, 8983, 9000, 9010-9016, 9020, 9030 | C000-C109, C129-C218, C239-C399, C480-C488, C500-C559, C570-C619, C630-C639, C659-C729, C750-C768, C809 | 116 |
XII. Other and unspecified malignant neoplasms | |||
(a) Other specified malignant tumors | 8930-8936, 8950, 8951, 8971-8981, 9050-9055, 9110 | C000-C809 | 121 |
9363 | C000-C399, C470-C759 | 121 | |
(b) Other unspecified malignant tumors | 8000-8005 | C000-C218, C239-C399, C420-C559, C570-C619, C630-C639, C659-C699, C739-C750, C754-C809 | 122 |
Not Classified by ICCC or in situ | 999 |
*. Steliarova-Foucher E, Stiller C, Lacour B, Kaatsch P. International Classification of Childhood Cancer, Third Edition. Cancer 2005;103:1457-67.